rs199510610
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_006440.5(TXNRD2):āc.656G>Cā(p.Gly219Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000206 in 1,613,864 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G219R) has been classified as Uncertain significance.
Frequency
Consequence
NM_006440.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TXNRD2 | NM_006440.5 | c.656G>C | p.Gly219Ala | missense_variant | 8/18 | ENST00000400521.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TXNRD2 | ENST00000400521.7 | c.656G>C | p.Gly219Ala | missense_variant | 8/18 | 1 | NM_006440.5 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000414 AC: 63AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000317 AC: 79AN: 249562Hom.: 0 AF XY: 0.000288 AC XY: 39AN XY: 135410
GnomAD4 exome AF: 0.000184 AC: 269AN: 1461562Hom.: 3 Cov.: 31 AF XY: 0.000173 AC XY: 126AN XY: 727112
GnomAD4 genome AF: 0.000414 AC: 63AN: 152302Hom.: 0 Cov.: 32 AF XY: 0.000430 AC XY: 32AN XY: 74466
ClinVar
Submissions by phenotype
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 05, 2023 | The p.G219A variant (also known as c.656G>C), located in coding exon 8 of the TXNRD2 gene, results from a G to C substitution at nucleotide position 656. The glycine at codon 219 is replaced by alanine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2021 | - - |
Primary dilated cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 25, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at